Use your antibodies-online credentials, if available.
RPN2 encodes a type I integral membrane protein found only in the rough endoplasmic reticulum. 再加上，我们可以发Ribophorin II 蛋白 (11) 和 Ribophorin II 试剂盒 (6)和数多这个蛋白质的别的产品。
Showing 10 out of 55 products:
Cow (Bovine) Polyclonal Ribophorin II Primary Antibody for IHC (p), IHC - ABIN266973
Ferrer, Boada Rovira, Sánchez Guerra, Rey, Costa-Jussá: Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. in Brain pathology (Zurich, Switzerland) 2004
Show all 2 Pubmed References
Human Polyclonal Ribophorin II Primary Antibody for IHC, IHC (p) - ABIN4350500
Wu, Hsu, Chen, Yu, Chang, Tai, Liu, Su, Chang, Yu: Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. in Molecular & cellular proteomics : MCP 2010
Human Polyclonal Ribophorin II Primary Antibody for IF, WB - ABIN519879
Baron, Pedrioli, Tyagi, Johnson, Wood, Fountaine, Wightman, Alexandru: VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase. in BMC biology 2014
Cow (Bovine) Polyclonal Ribophorin II Primary Antibody for IHC, WB - ABIN2782203
Shibatani, David, McCormack, Frueh, Skach: Proteomic analysis of mammalian oligosaccharyltransferase reveals multiple subcomplexes that contain Sec61, TRAP, and two potential new subunits. in Biochemistry 2005
Show all 2 Pubmed References
RPN2 (显示 PSMD1 抗体) expression correlates with gastric adenocarcinoma cell invasion and shows promise as a new prognostic factor in human gastric adenocarcinoma
Data suggest that RPN2 (显示 PSMD1 抗体) is involved in the regulation of lethal cancer phenotypes and represents a promising new target for RNAi-based medicine against non-small cell lung cancer.
Of the total, the deregulation of several genes (CDK1 (显示 CDK1 抗体), CDK2 (显示 CDK2 抗体), CDK4 (显示 CDK4 抗体), MCM2 (显示 MCM2 抗体), MCM3 (显示 MCM3 抗体), MCM4 (显示 MCM4 抗体), EIF3a (显示 EIF6 抗体) and RPN2 (显示 PSMD1 抗体)) were potentially associated with disease development and progression.
these results indicated that high glycosylation of CD63 (显示 CD63 抗体) by RPN2 (显示 PSMD1 抗体) is implicated in clinical outcomes in breast cancer patients
Furthermore, our study reveals that high expression of RPN2 (显示 PSMD1 抗体) and concomitant accumulation of mtp53 were associated with cancer tissues in a small cohort of metastatic breast cancer patients.
Rpn13 binding to the proteasome scaffolding protein hRpn2/S1 abrogates its interdomain interactions, thus activating hRpn13 for ubiquitin binding.
RPN2 (显示 PSMD1 抗体) gene confers docetaxel resistance in breast cancer.
S-glutathionylation of Rpn2 (显示 PSMD1 抗体) is a contributory mechanism for H2O2-induced inhibition of 26 S proteasomal function
Data show that the decay of metabolically labeled p53 (显示 TP53 抗体) follows biphasic kinetics, while 20 S proteasome executes the first phase by default, and the second phase requires the 26 S proteasome.
S-glutathionylation of Rpn2 is a contributory mechanism for H2O2-induced inhibition of 26 S proteasomal function
This gene encodes a type I integral membrane protein found only in the rough endoplasmic reticulum. The encoded protein is part of an N-oligosaccharyl transferase complex that links high mannose oligosaccharides to asparagine residues found in the Asn-X-Ser/Thr consensus motif of nascent polypeptide chains. This protein is similar in sequence to the yeast oligosaccharyl transferase subunit SWP1. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit
, dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2
, oligosaccharyltransferase complex subunit (non-catalytic)
, ribophorin 2
, ribophorin II
, ribophorin ii
, dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2-like
, ribophorin II S homeolog